touchPANEL DISCUSSION for touchRESPIRATORY
Listen to a panel of experts discuss using biologics to optimize outcomes for patients with type 2 asthma and how biomarkers can inform treatment decisions.
The experts
This touchPODCAST is for HCPs only.
This activity is funded by an unrestricted independent medical education grant from Sanofi Genzyme and Regeneron Pharmaceuticals. This activity is provided by touchIME.
For further information visit our website: https://touchrespiratoryime.org/pd-in-disease-control-in-moderate-to-severe-type-2-asthma/
Create your
podcast in
minutes
It is Free